NCT04988074: An ongoing trial by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This trial is ongoing. It must report results 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04988074 |
|---|---|
| Title | A Phase II Trial of Cemiplimab, or Cemiplimab-Chemotherapy, Followed by Biomarker-guided De-escalated Curative-intent Locoregional Treatment for Patients With Advanced HPV-related Head and Neck Cancer. The MINIMA Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 13, 2021 |
| Completion date | Nov. 12, 2025 |
| Required reporting date | Nov. 12, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |